● Recruiting

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Condition: Asthma · Sponsor: GlaxoSmithKline

PhasePhase 3

Planned participants292

Who can joinAll sexes, 12 Years to 17 Years

Healthy volunteersNo

About this study

The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (62)

GSK Investigational Site	Birmingham, Alabama, United States	Recruiting
GSK Investigational Site	Mobile, Alabama, United States	Recruiting
GSK Investigational Site	Paradise Valley, Arizona, United States	Recruiting
GSK Investigational Site	Bakersfield, California, United States	Recruiting
GSK Investigational Site	Mission Viejo, California, United States	Recruiting
GSK Investigational Site	Rolling Hills Estates, California, United States	Completed
GSK Investigational Site	Colorado Springs, Colorado, United States	Recruiting
GSK Investigational Site	Aventura, Florida, United States	Completed
GSK Investigational Site	Miami, Florida, United States	Recruiting
GSK Investigational Site	Miami, Florida, United States	Completed
GSK Investigational Site	Miami, Florida, United States	Recruiting
GSK Investigational Site	Savannah, Georgia, United States	Completed

+ 50 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05757102